Dr. Marc Ceusters, based at Janssen R&D Beerse, is the Compound Development Team Leader at Janssen R&D and responsible for projects in early development in neuroscience, including defining compound class and designing and executing project strategy and plan.
About Janssen Pharmaceutica Nv:
Janssen R&D is part of the Johnson & Johnson Group, a global market leader in healthcare products with more than 265 operational companies in 60 countries. Janssen is one of the most innovative pharmaceutical companies in the world, investing around $4.5 billion in research & development annually and is a top 10 company in global pharmaceutical sales.
Belgium is the largest Johnson & Johnson site outside the United States. Janssen has divided its different fields of expertise in Belgium into separate offices in Beerse (Beerse I and II), Geel, Olen, Merksem, Diegem, La Louvière, and Courcelles. Together, these organizations discover, develop, and produce medicines and therapeutic solutions for patients worldwide. Activities range from initial basic research and production to commercial and support services and sale of medicines.
Therefore, Janssen in Belgium controls the entire pharmaceutical cycle, something which is unique in the pharmaceutical world.